MedTrace Logo

Early Versus Late Use of Hi-VNI in Covid-19

NCT05663138 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2022-12-23

No results posted yet for this study

Summary

This study evaluate early administration of high-velocity nasal insufflation in COVID-19 patients presented with acute respiratory failure after failure of conventional low flow nasal cannula bypassing the escalating step of Non re-breathing mask where early use of High velocity nasal insufflations achieved better improvement of respiratory distress, lower oxygen requirements and shorter ICU stay.

Conditions

Sponsors & Collaborators

  • Aswan University

    collaborator OTHER

  • Assiut University

    lead OTHER

Principal Investigators

  • Lamees M Bakkar, Fellow · Fellow of Chest diseases Assiut University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-01
Primary Completion
2022-02-28
Completion
2022-03-15

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05663138 on ClinicalTrials.gov